| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/22/2009 | US20090023747 Cysteine Protease Inhibitors |
| 01/22/2009 | US20090023745 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/22/2009 | US20090023724 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 01/22/2009 | US20090023722 Amide substituted imidazoquinolines |
| 01/22/2009 | US20090023720 2-Amino 1H-Imidazo Ring Systems and Methods |
| 01/22/2009 | US20090023717 Morphine-bridged indazole derivatives |
| 01/22/2009 | US20090023703 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase |
| 01/22/2009 | US20090023702 Pyridone gpr119 g protein-coupled receptor agonists |
| 01/22/2009 | US20090022688 Inhibitors of serine protease, particularly hcv ns3-ns4a protease |
| 01/22/2009 | DE102007033020A1 Bispidonliganden und deren Metallkomplexe Bispidone ligands and metal complexes thereof |
| 01/22/2009 | CA2699971A1 Spiro condensed barbituric acid derivatives for use as antibacterial |
| 01/22/2009 | CA2695004A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/22/2009 | CA2693904A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | CA2693887A1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors |
| 01/22/2009 | CA2693473A1 Thiadiazole modulators of pkb |
| 01/22/2009 | CA2693232A1 Bicyclic heteroaryl compounds and their use as kinase inhibitors |
| 01/21/2009 | EP2017278A1 Dihydropyrazolopyrimidinone derivative |
| 01/21/2009 | EP2017277A1 Thiophene-imidazopyridines |
| 01/21/2009 | EP2017275A1 Benzisoxazole compound |
| 01/21/2009 | EP2016078A2 Pyrrolo- and thiazolo-pyridine compounds as hif modulators |
| 01/21/2009 | EP2016077A2 Pharmaceutical compounds |
| 01/21/2009 | EP2016047A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 01/21/2009 | EP1924580B1 Non-steroidal compounds useful as glucocorticoid receptor modulators |
| 01/21/2009 | EP1904477B1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 01/21/2009 | EP1863792B1 Atp competitive kinase inhibitors |
| 01/21/2009 | EP1509523B1 Triazaspiro compounds useful for treating or preventing pain |
| 01/21/2009 | CN101351466A Heterocyclic Janus kinase 3 inhibitors |
| 01/21/2009 | CN101351446A Novel fused pyrrole derivatives |
| 01/21/2009 | CN101351203A Use of pyrroloquinoline compounds to kill clinically latent microorganisms |
| 01/21/2009 | CN101348484A Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these |
| 01/21/2009 | CN101348483A Preparation of phenanthroindolizidine derivative |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN100454581C 有机薄膜晶体管 The organic thin film transistor |
| 01/21/2009 | CN100453553C Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/21/2009 | CN100453547C Inhibitors |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479558 Chemical intermediates |
| 01/20/2009 | US7479557 Iron, osmium, platinum, rhenium, or ruthenium metal complexes of naphthalenediimide derivatives having imidazole and/or morpholine groups; nucleic acid detection; imidation, complexing, hybridizaton, immobilization; genetic engineering |
| 01/20/2009 | US7479471 Applying to plants, seeds |
| 01/20/2009 | CA2376676C Respiratory syncytial virus replication inhibitors |
| 01/20/2009 | CA2366268C Pharmaceutical compositions for cns and other disorders |
| 01/15/2009 | WO2009009059A1 Spiro compounds as antagonists of tgf-beta |
| 01/15/2009 | WO2009009001A1 Crystalline pyridazine compound |
| 01/15/2009 | WO2009008748A1 Pyrazolo[1,5-a]pyridines and their use in cancer therapy |
| 01/15/2009 | WO2009008552A1 8-aryl-4-alkylpyrrolo[2,3,4-de]quinolin-5(4h)-one and 8-aryl-4-alkyl-4,5-dihydropyrrolo[2,3,4-de]quinolin-5-ol derivatives |
| 01/15/2009 | WO2009008353A1 Chrysene derivative and organic el device |
| 01/15/2009 | WO2009008303A1 Process for production of optically active mirtazapine |
| 01/15/2009 | WO2009007995A1 Process for preparing zolpidem and its intermediate |
| 01/15/2009 | WO2009007751A2 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 01/15/2009 | WO2009007536A2 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 01/15/2009 | WO2009007535A2 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 01/15/2009 | WO2009007028A1 Prodrug derivatives of 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine-3-carboxamide |
| 01/15/2009 | WO2008137027A3 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation |
| 01/15/2009 | WO2008124083A3 Aurora kinase modulators and method of use |
| 01/15/2009 | WO2008110699A3 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 01/15/2009 | WO2008091670A3 Organic semiconductor materials and precursors thereof |
| 01/15/2009 | US20090018336 Racemization process of R-zopiclone |
| 01/15/2009 | US20090018331 Condensed imidazole derivatives |
| 01/15/2009 | US20090018329 Novel heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors |
| 01/15/2009 | US20090018156 Pyrrolo [2,3,B] Pyridine Derivatives Useful As RAF Kinase Inhibitors |
| 01/15/2009 | US20090018130 Derivatives of 5-Aryl-1H-Pyrrolo [2, 3B] Pyridine-3-Carboxamide or 5-Aryl-1H-Pyrrolo [2, 3B] Pyridine-3-Carboxylic Acid |
| 01/15/2009 | US20090018129 compounds that interfere with tyrosine kinase signalling such as 1-{3-Amino-1-methyl-4-[4-(3-phenyl-ureido)-phenyl]-1H-pyrazolo[3,4-b]pyridin-6-yl}-cyclopropanecarboxylic acid ethyl ester, used for the treatment of diseases of dysregulated vascular growth such as retinopathy |
| 01/15/2009 | US20090018124 Novel Benzoimidazole Derivatives and Pharmaceutical Composition Comprising the Same |
| 01/15/2009 | US20090018122 Aryloxy and Arylalkyleneoxy Substituted Imidazoquinolines |
| 01/15/2009 | US20090018116 Therapeutic Compounds |
| 01/15/2009 | US20090018091 Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use |
| 01/15/2009 | US20090018056 Heteroarylcarbamoylbenzene derivatives |
| 01/15/2009 | US20090018055 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists |
| 01/15/2009 | US20090017489 Methods For Modulating The Development Of Dopamine Neuron By The Dopamine D2 Receptor And Compositions Thereof |
| 01/15/2009 | US20090017307 Process for the Preparation of Organic Materials |
| 01/15/2009 | DE102007032344A1 Prodrug-Derivate von Prodrug derivatives of 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3-carboxamid |
| 01/15/2009 | CA2692725A1 Compound - 946 |
| 01/15/2009 | CA2692653A1 Pyrazolo[1,5-.alpha.]pyridines and their use in cancer therapy |
| 01/15/2009 | CA2691917A1 Crystalline pyridazine compound |
| 01/15/2009 | CA2690349A1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 01/15/2009 | CA2690337A1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 01/14/2009 | EP2014659A1 New hybrid compounds of nucleobases and organic redox molecules and their use |
| 01/14/2009 | EP2013209A2 Pyrazolo-tetrahydropyridine derivatives as orexin receptor antagonists |
| 01/14/2009 | EP2013208A1 Pyridin[3,4-b]pyrazinones |
| 01/14/2009 | EP2013207A1 Imidazo[4, 5-b]pyridin-2-one and oxazolo[4, 5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds |
| 01/14/2009 | EP2013206A1 Pharmaceutical compounds |
| 01/14/2009 | EP2013205A1 Heterocyclic substituted, anellated pyrazole derivative and its uses |
| 01/14/2009 | EP2013204A2 2-aminopyridine analogs as glucokinase activators |
| 01/14/2009 | EP2013189A1 Dhfr enzyme inhibitors |
| 01/14/2009 | EP2013181A1 Pyridyl compounds |
| 01/14/2009 | EP2013170A1 4-squarylpiperazine derivatives as antiviral agents |
| 01/14/2009 | EP2012789A1 Method of treatment of age-related macular degeneration(amd) |
| 01/14/2009 | EP1668014B1 Fused heterocyclic compounds as serotonin receptor modulators |
| 01/14/2009 | EP1560584B1 Fab i inhibitors |
| 01/14/2009 | EP1487486B1 Imidazoquinolineamines as adjuvants in hiv dna vaccination |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | EP1436291B1 Indolizines as kinase protein inhibitors |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 01/14/2009 | EP1183025B1 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 01/14/2009 | CN101346437A Trisazo compound, ink composition, recording method and colored matter |
| 01/14/2009 | CN101346380A Pyrimidine derivatives for the treatment of abnormal cell growth |
| 01/14/2009 | CN101346379A Peri condensed tricyclic compounds useful as antibacterial agents |